查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
粒子束治疗的全球市场（2024-2033）：按产品和服务、应用、癌症类型、类型、系统和国家（超过 16 个国家）进行分析和预测
市场调查报告书
商品编码
1397355

粒子束治疗的全球市场（2024-2033）：按产品和服务、应用、癌症类型、类型、系统和国家（超过 16 个国家）进行分析和预测

Global Particle Therapy Market: Focus on Products and Services, Application, Cancer Type, Type, System, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 134 Pages | 商品交期: 1-5个工作天内

价格

粒子疗法是一种特殊型态的外束放射疗法，利用高能量质子、中子或重阳离子，在癌症治疗中越来越受到关注。

推动市场扩张的主要因素是癌症盛行率的增加、临床研究中越来越多地采用粒子治疗、不断的技术进步以及全球粒子治疗中心的激增。

本报告调查了全球粒子束治疗市场并提供了市场背景和概述，分析了市场成长的各种影响因素、专利趋势、法律制度、市场规模趋势和预测以及各种分类和区域。我们总结了详细的分析、竞争形势、主要企业分析等

市场分类

细分1：按用途

  • 治疗
  • 研究

细分 2：依癌症类型

  • 儿童癌症
  • 肺癌
  • 乳癌
  • 头颈癌
  • 其他癌症

细分 3：按类型

  • 质子治疗
  • 重粒子线治疗

细分 4：依系统划分

  • 多房间系统
  • 单间系统

细分 6：按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

目录

执行摘要

范围/定义

第一章 市场

  • 趋势：当前和未来的影响评估
  • 供应链概览
    • 价值链分析
    • 市场地图
  • 研发回顾
    • 按国家和公司分類的专利申请趋势
  • 监管状况
  • 全球重大事件 COVID-19 的影响分析
  • 市场动态概览
    • 市场驱动因素
    • 市场抑制因素
    • 市场机会

第二章 应用

  • 使用分类
  • 应用概述
  • 全球粒子束治疗市场（按应用）
    • 流程
    • 调查
  • 全球粒子束治疗市场（按癌症类型）
    • 儿童癌症
    • 肺癌
    • 乳癌
    • 头颈癌
    • 其他癌症

第三章 产品

  • 产品分类
  • 产品概要
  • 全球粒子治疗市场（按产品和服务）
    • 产品
    • 服务
  • 全球粒子束治疗市场（按类型）
    • 质子治疗
    • 重粒子线治疗
  • 全球粒子束治疗市场（按系统）
    • 多房间系统
    • 单间系统

第四章 区域

  • 区域概况
  • 促进因素/抑制因素
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第五章市场：竞争基准化分析/公司简介

  • 下一个前沿
  • 区域评估
    • Advanced Oncotherapy Plc.
    • Biosig Technologies, Inc.
    • Danfysik A/S
    • Elekta
    • Hitachi Ltd.
    • IBA
    • Mevion Medical Systems
    • Panacea Medical Technologies
    • Optivus Proton Therapy, Inc.
    • P-Cure
    • ProTom International
    • Provision Healthcare
    • Siemens Healthcare GmbH (Variant Medical Systems, Inc.)
    • Sumitomo Heavy Industries, Ltd.
    • Toshiba Medical Systems Corp.

第六章调查方法

Product Code: BHR1668SA

“Global Particle Therapy Market Surges Ahead with Unprecedented Growth.”

Particle therapy, a specialized form of external beam radiotherapy utilizing energetic protons, neutrons, or heavy positive ions, is gaining traction in cancer treatment. Market expansion is primarily propelled by factors such as the increasing incidence of cancer, heightened adoption of particle therapy in clinical research, continual technological advancements, and the proliferation of particle therapy centres worldwide.

The study evaluates the competitive landscape, profiling leading players, and assessing their strategies to gain a competitive edge. Additionally, the report discusses the factors driving market growth, challenges and potential risks are addressed, aiding stakeholders in making informed decisions.

With a blend of quantitative and qualitative analysis, this report serves as a valuable resource for industry participants, investors, and decision-makers seeking to understand the dynamics of the global particle therapy market.

Market Segmentation:

Segmentation 1: by Application

  • Treatment
  • Research

Segmentation 2: by Cancer Type

  • Paediatric Cancer
  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancer
  • Other Cancers

Segmentation 3: by Type

  • Proton Therapy
  • Heavy-Ion Therapy

Segmentation 4: by System

  • Multi-room Systems
  • Single-room Systems

Segmentation 6: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

Key Questions Answered in this Report:

  • 1. What is the present size of the global market for particle therapy?
  • 2. Who are the major contributors in the global particle therapy Market?
  • 3. Which region is experiencing the most rapid growth in the global particle therapy Market?
  • 4. Which geographical area holds the largest portion of the global particle therapy Market?
  • 5. What is the projected Compound Annual Growth Rate (CAGR) for the particle therapy market?
  • 6. What are the primary factors propelling growth in the particle therapy market?
  • 7. Which sector is predicted to spearhead the particle therapy market by 2033?

Table of Contents

Executive Summary

Scope and Definition

1. Markets

  • 1.1. Trends: Current and Future Impact Assessment
    • 1.1.1. Sample Text
    • 1.1.2. Trend 1- Technological Advancements
    • 1.1.3. Trend 2
    • 1.1.4. Trend 3
  • 1.2. Supply Chain Overview
    • 1.2.1. Value Chain Analysis
    • 1.2.2. Market Map
  • 1.3. Research and Development Review
    • 1.3.1. Patent Filing Trend (by Country, Company)
  • 1.4. Regulatory Landscape
  • 1.5. Impact Analysis for Key Global Events- Covid19
  • 1.6. Market Dynamics Overview
    • 1.6.1. Market Drivers
    • 1.6.2. Market Restraints
    • 1.6.3. Market Opportunities

2. Application

  • 2.1. Application Segmentation
  • 2.2. Application Summary
  • 2.3. Global Particle Therapy Market (by Application)
    • 2.3.1. Treatment
    • 2.3.2. Research
  • 2.4. Global Particle Therapy Market (by Cancer Type)
    • 2.4.1. Paediatric Cancer
    • 2.4.2. Lung Cancer
    • 2.4.3. Breast Cancer
    • 2.4.4. Head and Neck Cancer
    • 2.4.5. Other Cancers

3. Products

  • 3.1. Product Segmentation
  • 3.2. Product Summary
  • 3.3. Global Particle Therapy Market (by Products and Services)
    • 3.3.1. Products
    • 3.3.2. Services
  • 3.4. Global Particle Therapy Market (by Type)
    • 3.4.1. Proton Therapy
    • 3.4.2. Heavy-Ion Therapy
  • 3.5. Global Particle Therapy Market (By System)
    • 3.5.1. Multi-room Systems
    • 3.5.2. Single-room Systems

4. Regions

  • 4.1. Regional Summary
  • 4.2. Drivers and Restraints as you go alone……
  • 4.3. North America
    • 4.3.1. Regional Overview
    • 4.3.2. Driving Factors for Market Growth
    • 4.3.3. Factors Challenging the Market
    • 4.3.4. Application
    • 4.3.5. Product
    • 4.3.6. U.S.
    • 4.3.7. U.S. Particle Therapy Market by Application
    • 4.3.8. Canada
    • 4.3.9. Canada Particle Therapy Market by Application
  • 4.4. Europe
    • 4.4.1. Regional Overview
    • 4.4.2. Driving Factors for Market Growth
    • 4.4.3. Factors Challenging the Market
    • 4.4.4. Application
    • 4.4.5. Product
    • 4.4.6. France
    • 4.4.7. France Particle Therapy Market by Application
    • 4.4.8. Germany
    • 4.4.9. Germany Particle Therapy Market by Application
    • 4.4.10. U.K.
    • 4.4.11. U.K. Particle Therapy Market by Application
    • 4.4.12. Rest of Europe
    • 4.4.13. Rest of Europe Particle Therapy Market by Application
  • 4.5. Asia Pacific
    • 4.5.1. Regional Overview
    • 4.5.2. Driving Factors for Market Growth
    • 4.5.3. Factors Challenging the Market
    • 4.5.4. Application
    • 4.5.5. Product
    • 4.5.6. China
    • 4.5.7. China Particle Therapy Market by Application
    • 4.5.8. India
    • 4.5.9. India Particle Therapy Market by Application
    • 4.5.10. Japan
    • 4.5.11. Japan Particle Therapy Market by Application
    • 4.5.12. Rest-of-Asia-Pacific
    • 4.5.13. Rest-of-Asia-Pacific Particle Therapy Market by Application
  • 4.6. Rest-of-the-World
    • 4.6.1. Regional Overview
    • 4.6.2. Driving Factors for Market Growth
    • 4.6.3. Factors Challenging the Market
    • 4.6.4. Application
    • 4.6.5. Product
    • 4.6.6. The Middle East and Africa
    • 4.6.7. The Middle East and Africa Particle Therapy Market by Application
    • 4.6.8. Latin America
    • 4.6.9. Latin America Particle Therapy Market by Application

5. Markets - Competitive Benchmarking & Company Profiles

  • 5.1. Next Frontiers
  • 5.2. Geographic Assessment
    • 5.2.1. Advanced Oncotherapy Plc.
      • 5.2.1.1. Overview
      • 5.2.1.2. Top Products / Product Portfolio
      • 5.2.1.3. Top Competitors
      • 5.2.1.4. Target Customers
      • 5.2.1.5. Key Personnel
      • 5.2.1.6. Analyst View
      • 5.2.1.7. Market Share
    • 5.2.2. Biosig Technologies, Inc.
      • 5.2.2.1. Overview
      • 5.2.2.2. Top Products / Product Portfolio
      • 5.2.2.3. Top Competitors
      • 5.2.2.4. Target Customers
      • 5.2.2.5. Key Personnel
      • 5.2.2.6. Analyst View
      • 5.2.2.7. Market Share
    • 5.2.3. Danfysik A/S
      • 5.2.3.1. Overview
      • 5.2.3.2. Top Products / Product Portfolio
      • 5.2.3.3. Top Competitors
      • 5.2.3.4. Target Customers
      • 5.2.3.5. Key Personnel
      • 5.2.3.6. Analyst View
      • 5.2.3.7. Market Share
    • 5.2.4. Elekta
      • 5.2.4.1. Overview
      • 5.2.4.2. Top Products / Product Portfolio
      • 5.2.4.3. Top Competitors
      • 5.2.4.4. Target Customers
      • 5.2.4.5. Key Personnel
      • 5.2.4.6. Analyst View
      • 5.2.4.7. Market Share
    • 5.2.5. Hitachi Ltd.
      • 5.2.5.1. Overview
      • 5.2.5.2. Top Products / Product Portfolio
      • 5.2.5.3. Top Competitors
      • 5.2.5.4. Target Customers
      • 5.2.5.5. Key Personnel
      • 5.2.5.6. Analyst View
      • 5.2.5.7. Market Share
    • 5.2.6. IBA
      • 5.2.6.1. Overview
      • 5.2.6.2. Top Products / Product Portfolio
      • 5.2.6.3. Top Competitors
      • 5.2.6.4. Target Customers
      • 5.2.6.5. Key Personnel
      • 5.2.6.6. Analyst View
      • 5.2.6.7. Market Share
    • 5.2.7. Mevion Medical Systems
      • 5.2.7.1. Overview
      • 5.2.7.2. Top Products / Product Portfolio
      • 5.2.7.3. Top Competitors
      • 5.2.7.4. Target Customers
      • 5.2.7.5. Key Personnel
      • 5.2.7.6. Analyst View
      • 5.2.7.7. Market Share
    • 5.2.8. Panacea Medical Technologies
      • 5.2.8.1. Overview
      • 5.2.8.2. Top Products / Product Portfolio
      • 5.2.8.3. Top Competitors
      • 5.2.8.4. Target Customers
      • 5.2.8.5. Key Personnel
      • 5.2.8.6. Analyst View
      • 5.2.8.7. Market Share
    • 5.2.9. Optivus Proton Therapy, Inc.
      • 5.2.9.1. Overview
      • 5.2.9.2. Top Products / Product Portfolio
      • 5.2.9.3. Top Competitors
      • 5.2.9.4. Target Customers
      • 5.2.9.5. Key Personnel
      • 5.2.9.6. Analyst View
      • 5.2.9.7. Market Share
    • 5.2.10. P-Cure
      • 5.2.10.1. Overview
      • 5.2.10.2. Top Products / Product Portfolio
      • 5.2.10.3. Top Competitors
      • 5.2.10.4. Target Customers
      • 5.2.10.5. Key Personnel
      • 5.2.10.6. Analyst View
      • 5.2.10.7. Market Share
    • 5.2.11. ProTom International
      • 5.2.11.1. Overview
      • 5.2.11.2. Top Products / Product Portfolio
      • 5.2.11.3. Top Competitors
      • 5.2.11.4. Target Customers
      • 5.2.11.5. Key Personnel
      • 5.2.11.6. Analyst View
      • 5.2.11.7. Market Share
    • 5.2.12. Provision Healthcare
      • 5.2.12.1. Overview
      • 5.2.12.2. Top Products / Product Portfolio
      • 5.2.12.3. Top Competitors
      • 5.2.12.4. Target Customers
      • 5.2.12.5. Key Personnel
      • 5.2.12.6. Analyst View
      • 5.2.12.7. Market Share
    • 5.2.13. Siemens Healthcare GmbH (Variant Medical Systems, Inc.)
      • 5.2.13.1. Overview
      • 5.2.13.2. Top Products / Product Portfolio
      • 5.2.13.3. Top Competitors
      • 5.2.13.4. Target Customers
      • 5.2.13.5. Key Personnel
      • 5.2.13.6. Analyst View
      • 5.2.13.7. Market Share
    • 5.2.14. Sumitomo Heavy Industries, Ltd.
      • 5.2.14.1. Overview
      • 5.2.14.2. Top Products / Product Portfolio
      • 5.2.14.3. Top Competitors
      • 5.2.14.4. Target Customers
      • 5.2.14.5. Key Personnel
      • 5.2.14.6. Analyst View
      • 5.2.14.7. Market Share
    • 5.2.15. Toshiba Medical Systems Corp.
      • 5.2.15.1. Overview
      • 5.2.15.2. Top Products / Product Portfolio
      • 5.2.15.3. Top Competitors
      • 5.2.15.4. Target Customers
      • 5.2.15.5. Key Personnel
      • 5.2.15.6. Analyst View
      • 5.2.15.7. Market Share

6. Research Methodology

  • 6.1. Data Sources
    • 6.1.1. Primary Data Sources
    • 6.1.2. Secondary Data Sources
    • 6.1.3. Data Triangulation
  • 6.2. Market Estimation and Forecast

List of Figures

  • Figure 1: Global Particle Therapy Market, Region/country Largest Share
  • Figure 2: Pricing/Cost Analysis by Region, Supply Chain
  • Figure 3: Global Particle Therapy Market, by Application, 2022, 2026, and 2033
  • Figure 4: Global Particle Therapy Market, by Cancer Type, 2022, 2026, and 2033
  • Figure 5: Global Particle Therapy Market, by Product and Services, 2022, 2026, and 2033
  • Figure 6: Global Particle Therapy Market, Therapy Type, 2022, 2026, 2033
  • Figure 7: Global Particle Therapy Market, Recent Developments
  • Figure 8: Supply Chain and Identifying Risks within the Supply Chain
  • Figure 9: Global Particle Therapy Market, January 2020-December 2023
  • Figure 10: Global Particle Therapy Market, January 2020-December 2022
  • Figure 11: Impact Analysis of Market Navigating Factors
  • Figure 12: U.S. Particle Therapy Market, By Application ($Million), 2022. 2026, and 2033
  • Figure 13: U.S. Particle Therapy Market, By Cancer Type ($Million), 2022. 2026, and 2033
  • Figure 14: Canada Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 15: Canada Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 16: France Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 17: France Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 18: Germany Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 19: Germany Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 20: U.K. Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 21: U.K. Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 22: Rest of Europe Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 23: Rest of Europe Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 24: China Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 25: China Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 26: India Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 27: India Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 28: Japan Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 29: Japan Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 30: Rest-of-Asia-Pacific Particle Therapy Market, By Application ($ Million), 2022, 2026, and 2033
  • Figure 31: Rest-of-Asia-Pacific Particle Therapy Market, By Cancer Type ($ Million), 2022, 2026, and 2033
  • Figure 32: The Middle East and Africa Particle Therapy Market, By Application ($Million), 2022. 2026, and 2033
  • Figure 33: The Middle East and Africa Particle Therapy Market, By Cancer Type ($Million), 2022. 2026, and 2033
  • Figure 34: Latin America Particle Therapy Market, By Application ($ Million), 2022. 2026, and 2033
  • Figure 35: Latin America Particle Therapy Market, By Cancer Type ($ Million), 2022. 2026, and 2033
  • Figure 36: Strategic Initiatives, 2020 - 2023
  • Figure 37: Share of Strategic Initiatives
  • Figure 38: Data Triangulation
  • Figure 39: Top-Down and Bottom-Up Approach
  • Figure 40: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Particle Therapy Market, Opportunity
  • Table 3: Global Particle Therapy Market, By Region, ($Million), 2022-2033
  • Table 4: North America Particle Therapy Market, By Application ($ Million), 2022-2033
  • Table 5: North America Particle Therapy Market, By Cancer Type ($ Million), 2022-2033
  • Table 6: North America Particle Therapy Market, By Type ($ Million), 2022-2033
  • Table 7: U.S. Particle Therapy Market, By Application ($ Million), 2022-2033
  • Table 8: U.S. Particle Therapy Market, By Cancer Type ($ Million), 2022-2033
  • Table 9: Canada Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 10: Canada Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 11: Europe Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 12: Europe Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 13: Europe Particle Therapy Market, By Type ($ Million), 2022-2033
  • Table 14: France Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 15: France Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 16: Germany Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 17: Germany Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 18: U.K. Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 19: U.K. Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 20: Rest of Europe Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 21: Rest of Europe Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 22: Asia Pacific Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 23: Asia Pacific Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 24: Asia Pacific Particle Therapy Market, By Type ($ Million), 2022-2033
  • Table 25: China Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 26: China Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 27: India Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 28: India Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 29: Japan Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 30: Japan Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 31: Rest of Asia-Pacific Particle Therapy Market, By Application ($ Million), 2022-2033
  • Table 32: Rest of Asia-Pacific Particle Therapy Market, By Cancer Type ($ Million), 2022-2033
  • Table 33: Rest-of-the-World Particle Therapy Market, By Application ($ Million), 2022-2033
  • Table 34: Rest-of-the-World Particle Therapy Market, By Cancer Type ($ Million), 2022-2033
  • Table 35: Rest-of-the-World Particle Therapy Market, By Type ($ Million), 2022-2033
  • Table 36: The Middle East and Africa Particle Therapy Market, By Application ($ Million), 2022-2033
  • Table 37: The Middle East and Africa Particle Therapy Market, By Cancer Type ($ Million), 2022-2033
  • Table 38: Latin America Particle Therapy Market, By Application ($Million), 2022-2033
  • Table 39: Latin America Particle Therapy Market, By Cancer Type ($Million), 2022-2033
  • Table 40: Market Share